Nkarta, Inc. (NKTX)
NASDAQ·Healthcare·Biotechnology
$2.77
-2.12%
Mkt Cap $201.75M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | — | — | — | -$0.32 | -$0.37 | -15.62% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.32 | -$0.29 | +9.38% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.37 | -$0.31 | +16.22% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.44 | -$0.43 | +2.27% | — | — |
| Q1 2025 Mar 26, 2025 | — | — | — | -$0.41 | -$0.35 | +14.63% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.37 | -$0.39 | -5.41% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.49 | -$0.34 | +30.61% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.56 | -$0.58 | -3.57% | — | — |
| Q1 2024 Mar 21, 2024 | — | $10.54M | — | -$0.62 | -$0.57 | +8.06% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.67 | -$0.52 | +22.39% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.69 | -$0.68 | +1.45% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.71 | -$0.63 | +11.27% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$0.65 | -$0.67 | -3.08% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.62 | -$0.58 | +6.45% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.59 | -$0.48 | +18.64% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.73 | -$0.63 | +13.70% | — | — |
| Q1 2022 Mar 17, 2022 | — | — | — | -$0.75 | -$0.69 | +8.00% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.71 | -$0.68 | +4.23% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.65 | -$0.66 | -1.54% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.53 | -$0.59 | -11.32% | — | — |